Iovance Biotherapeutics, Inc. (IOVA)
2.205
-0.04
(-2.00%)
USD |
NASDAQ |
Dec 10, 11:16
Iovance Biotherapeutics Total Assets (Quarterly): 904.95M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | 18.67M |
| Talphera, Inc. | 30.74M |
| Lantheus Holdings, Inc. | 2.276B |
| iRhythm Technologies, Inc. | 995.21M |
| Day One Biopharmaceuticals, Inc. | 513.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 202.66M |
| Shareholders Equity (Quarterly) | 702.29M |
| Debt to Equity Ratio | 0.0747 |
| Current Ratio | 3.411 |
| Net Debt Paydown Yield | 0.70% |